BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10971353)

  • 1. Management difficulties due to concurrent dermatitis herpetiformis and variegate porphyria.
    Varma S; Lanigan SW
    Br J Dermatol; 2000 Sep; 143(3):654-5. PubMed ID: 10971353
    [No Abstract]   [Full Text] [Related]  

  • 2. [An Antilles fever. Dapsone allergy].
    Permal-Griffiths S; Dhôte R; Delègue P; Vayre L; Christoforov B
    Rev Med Interne; 2001 Jun; 22 Suppl 2():250s-252s. PubMed ID: 11433585
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinstatement of dapsone following hypersensitivity.
    Labandeira J; Toribio J
    Acta Derm Venereol; 2003; 83(4):314-5. PubMed ID: 12926815
    [No Abstract]   [Full Text] [Related]  

  • 4. Anterior ischaemic optic neuropathy associated with Dapsone.
    Chalioulias K; Mayer E; Darvay A; Antcliff R
    Eye (Lond); 2006 Aug; 20(8):943-5. PubMed ID: 16215545
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal liver function tests induced by dapsone in a patient with dermatitis herpetiformis and primary sclerosing cholangitis.
    Kirby B; Keaveney A; Brophy D; O'Donoghue D; Rogers S
    Br J Dermatol; 1999 Jul; 141(1):172-3. PubMed ID: 10417547
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin E for dapsone-induced headache.
    Cox NH
    Br J Dermatol; 2002 Jan; 146(1):174. PubMed ID: 11841391
    [No Abstract]   [Full Text] [Related]  

  • 7. Fine points in the management of dermatitis herpetiformis.
    Fry L
    Semin Dermatol; 1988 Sep; 7(3):206-11. PubMed ID: 3153446
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe dapsone hypersensitivity syndrome.
    Sener O; Doganci L; Safali M; Besirbellioglu B; Bulucu F; Pahsa A
    J Investig Allergol Clin Immunol; 2006; 16(4):268-70. PubMed ID: 16889287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine and dermatitis herpetiformis.
    Willsteed E; Lee M; Wong LC; Cooper A
    Australas J Dermatol; 2005 May; 46(2):101-3. PubMed ID: 15842404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and management of dermatitis herpetiformis.
    Leonard JN; Fry L
    Clin Dermatol; 1991; 9(3):403-8. PubMed ID: 1806228
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of dermatitis herpetiformis.
    Fry L
    Clin Exp Dermatol; 1982 Nov; 7(6):633-42. PubMed ID: 6758995
    [No Abstract]   [Full Text] [Related]  

  • 12. Localized facial macules and vesicles.
    Kaplan AL; Lee LH; Hall RP
    Arch Dermatol; 2004 Mar; 140(3):353-8. PubMed ID: 15023780
    [No Abstract]   [Full Text] [Related]  

  • 13. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term remission in patients with dermatitis herpetiformis on a normal diet.
    Bardella MT; Fredella C; Trovato C; Ermacora E; Cavalli R; Saladino V; Prampolini L
    Br J Dermatol; 2003 Nov; 149(5):968-71. PubMed ID: 14632800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatitis herpetiformis: effect of gluten-restricted and gluten-free diet on dapsone requirement and on IgA and C3 deposits in uninvolved skin.
    Ljunghall K; Tjernlund U
    Acta Derm Venereol; 1983; 63(2):129-36. PubMed ID: 6189327
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical signs for the general dental practitioner. Dermatitis herpetiformis.
    Bain S
    Dent Update; 2006 Jun; 33(5):316. PubMed ID: 16841614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.